Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Journal:

Journal of Clinical Oncology

Published:

2025-06-01

DOI:

10.1200/jco-25-00746

Affiliations:

24

Authors:

212

Go to article

Institutions	Authors	Share
Henry Ford Hospital, HFHS, United States of America (USA)	1.000000	0.05
Cedars-Sinai Medical Center (Cedars-Sinai), United States of America (USA)	1.000000	0.05
Changhai Hospital, SMMU, China	1.000000	0.05
Mayo Clinic's Campus in Florida, United States of America (USA)	1.000000	0.05
Ulm University Medical Center, Germany	1.000000	0.05
National Cancer Center (NCC), South Korea	1.000000	0.05
University Hospital Olomouc, PU, Czech Republic	1.000000	0.05
Maria Sklodowska-Curie National Research Institute of Oncology, Poland	1.000000	0.05
Virginia Mason Medical Center (Virginia Mason), United States of America (USA)	1.000000	0.05
Baptist MD Anderson Cancer Center, United States of America (USA)	1.000000	0.05
National Institute of Oncology (NIO), Hungary	1.000000	0.05
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.05
Centre Léon Bérard (CLB), France	1.000000	0.05
KU Cancer Center, United States of America (USA)	1.000000	0.05
Cancer and Hematology Centers of Western Michigan, United States of America (USA)	1.000000	0.05
Hospital Regional Universitario de Málaga, Spain	1.000000	0.05
Catholic University of Leuven (KU Leuven), Belgium	1.000000	0.05
Kanagawa Cancer Center, Japan	1.000000	0.05
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	1.000000	0.05
Hospital General Universitario de Elche, Spain	1.000000	0.05
St John of God Murdoch Hospital, Australia	1.000000	0.05
Harvard Medical School (HMS), United States of America (USA)	0.500000	0.02
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	0.500000	0.02

Interested in Oncology and Carcinogenesis?